WHO-klassificeringen i 2008 af lymfoide neoplasmer og fortid: ideer under udvikling og fornuftige formål
Verdenssundhedsorganisationens klassificering af lymfoide neoplasmer opdateret i 2008 repræsenterer en verdensomspændende enighed om diagnosen af disse tumorer og er baseret på anerkendelsen af forskellige sygdomme ved hjælp af en tværfaglig tilgang. Den opdaterede klassificering forbedrede definitionerne af velkendte sygdomme, identificerede nye enheder og varianter og inkorporerede nye begreber i forståelsen af lymfoide neoplasmer.
- Nogle spørgsmål var imidlertid uafviklede, såsom i hvilket omfang specifikke genetiske eller molekylære ændringer definerer visse tumorer, og standing som foreløbige enheder, kategorier, som arbejdsgrupperne fra Verdenssundhedsorganisationen mente, at der ikke var tilstrækkelig bevis til at anerkende som forskellige sygdomme ved dette tid.
- Derudover er der siden offentliggørelsen blevet genereret nye fund og ideer. Denne gennemgang opsummerer den videnskabelige begrundelse for klassificeringen og understregede ændringer, der har haft effekt på praksisretningslinjerne.
- Forfatterne adresserer kriterierne og betydningen af tidlige eller forløberlæsioner og identificeringen af visse lymfoide neoplasmer, der stort set er forbundet med bestemte aldersgrupper, såsom børn og ældre.
- Spørgsmålet om grænsekategorier, der har overlappende funktioner med retailer B-celle lymfomer, samt flere midlertidige enheder, gennemgås. Disse nye observationer kortlægger et kursus for fremtidig forskning på området.
Recombinant Human T-cell Leukemia/Lymphoma 1A |
|||
| MBS143923-5x1mg | MyBiosource | 5x1mg | EUR 8540 |
T-cell Leukemia/Lymphoma 1A Human Recombinant |
|||
| rAP-4935 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human T-cell leukemia/lymphoma protein 1A (TCL1A) |
|||
| MBS717878-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1035 |
Recombinant Human T-cell leukemia/lymphoma protein 1A (TCL1A) |
|||
| MBS717878-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 615 |
Recombinant Human T-cell leukemia/lymphoma protein 1A (TCL1A) |
|||
| MBS717878-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 790 |
Recombinant Human T-cell leukemia/lymphoma protein 1A (TCL1A) |
|||
| MBS717878-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 715 |
Recombinant Human T-cell leukemia/lymphoma protein 1A (TCL1A) |
|||
| MBS717878-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 925 |
Recombinant Human T-cell Leukemia/Lymphoma 1B |
|||
| MBS146454-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human T-cell Leukemia/Lymphoma 1B |
|||
| MBS146454-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human T-cell Leukemia/Lymphoma 1B |
|||
| MBS146454-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human T-cell Leukemia/Lymphoma 1B |
|||
| MBS146454-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
T-cell Leukemia/Lymphoma 1B Human Recombinant |
|||
| rAP-4934 | Angio Proteomie | Inquiry | Ask for price |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2029881-001mg | MyBiosource | 0.01mg | EUR 175 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2029881-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2029881-01mg | MyBiosource | 0.1mg | EUR 490 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2029881-02mg | MyBiosource | 0.2mg | EUR 595 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2029881-05mg | MyBiosource | 0.5mg | EUR 1130 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2031719-001mg | MyBiosource | 0.01mg | EUR 170 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2031719-005mg | MyBiosource | 0.05mg | EUR 300 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2031719-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2031719-02mg | MyBiosource | 0.2mg | EUR 550 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| MBS2031719-05mg | MyBiosource | 0.5mg | EUR 1050 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPU55294-100ug | Biomatik Corporation | 100ug | EUR 576.4 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPU55294-1mg | Biomatik Corporation | 1mg | EUR 2555.8 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPU55294-50ug | Biomatik Corporation | 50ug | EUR 463.1 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPU43960-100ug | Biomatik Corporation | 100ug | EUR 530.2 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPU43960-1mg | Biomatik Corporation | 1mg | EUR 2347.8 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPU43960-50ug | Biomatik Corporation | 50ug | EUR 425.7 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPB709Hu01 | Cloud-Clone | 10ug | EUR 172 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| 4-RPB709Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human T-Cell Leukemia/Lymphoma Protein 1A expressed in: E.coli |
|||
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| RPB709Ra01 | Cloud-Clone | 10ug | EUR 187 |
Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) |
|||
| 4-RPB709Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat T-Cell Leukemia/Lymphoma Protein 1A expressed in: E.coli |
|||
Recombinant human T-cell leukemia/lymphoma protein 1B |
|||
| P1275 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human T-cell leukemia/lymphoma protein 1B |
|||
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (AP) |
|||
| MBS6134972-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (AP) |
|||
| MBS6134972-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (AP) |
|||
| MBS6134973-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (AP) |
|||
| MBS6134973-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (PE) |
|||
| MBS6161487-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (PE) |
|||
| MBS6161487-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (PE) |
|||
| MBS6161488-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (PE) |
|||
| MBS6161488-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (HRP) |
|||
| MBS6156184-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (HRP) |
|||
| MBS6156184-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (HRP) |
|||
| MBS6156185-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (HRP) |
|||
| MBS6156185-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) APC |
|||
| MBS6140275-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) APC |
|||
| MBS6140275-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) APC |
|||
| MBS6140276-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) APC |
|||
| MBS6140276-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (FITC) |
|||
| MBS6150881-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (FITC) |
|||
| MBS6150881-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (FITC) |
|||
| MBS6150882-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (FITC) |
|||
| MBS6150882-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (Biotin) |
|||
| MBS6145578-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (Biotin) |
|||
| MBS6145578-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (Biotin) |
|||
| MBS6145579-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (Biotin) |
|||
| MBS6145579-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| CSB-EP023313MO | Cusabio | 11346 mg | Ask for price |
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| CSB-EP023313MO-100ug | Cusabio | 100ug | Ask for price |
|
Description: 1-116aa |
|||
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| CSB-EP023313MO-1mg | Cusabio | 1mg | Ask for price |
|
Description: 1-116aa |
|||
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| CSB-EP023313MO-20ug | Cusabio | 20ug | Ask for price |
|
Description: 1-116aa |
|||
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| MBS949761-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1035 |
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| MBS949761-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 610 |
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| MBS949761-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 785 |
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| MBS949761-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 710 |
Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a) |
|||
| MBS949761-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 920 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 750) |
|||
| MBS6237004-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 750) |
|||
| MBS6237004-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 750) |
|||
| MBS6237005-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 750) |
|||
| MBS6237005-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 405) |
|||
| MBS6194304-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 405) |
|||
| MBS6194304-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 405) |
|||
| MBS6194305-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 405) |
|||
| MBS6194305-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 650) |
|||
| MBS6226329-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 650) |
|||
| MBS6226329-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 650) |
|||
| MBS6226330-01mL | MyBiosource | 0.1(mL | EUR 875 |
TCL1A (T-Cell Leukemia/lymphoma 1A, T-Cell Lymphoma-1, T-Cell Lymphoma-1A, TCL1) (MaxLight 650) |
|||
| MBS6226330-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Værtsbakterielle interaktioner i Helicobacter pylori-infektion.
Helicobacter pylori er spiralformede gramnegative bakterier med polær flagella, der lever nær overfladen af den humane gastriske slimhinde. De har udviklet komplicerede mekanismer til at undgå bakteriedræbende syre i gastrisk lumen og for at overleve i nærheden, at binde sig til og kommunikere med det humane gastriske epitel og værtsimmunsystem.
Denne interaktion resulterer undertiden i svær gastrisk patologi. H pylori-infektion er den stærkeste kendte risikofaktor for udvikling af gastroduodenalsår, idet infektion er til stede i 60% -80% gastrisk og 95% af duodenalsår. (1) H pylori er også den første bakterie, der klassificeres som en bestemt kræftfremkaldende stof af Verdenssundhedsorganisationens internationale agentur for kræftforskning på grund af dets epidemiologiske forhold til gastrisk adenocarcinom og gastrisk slimhinde-associeret lymfoide vævslymfom.
(2) I de sidste 25 år, siden H pylori først blev beskrevet og dyrket, blev en komplet Der er sket paradigmeskift i vores kliniske tilgang til disse gastriske sygdomme, og mere finish 20.000 videnskabelige publikationer har vist sig om emnet.
Fra det medicinske synspunkt er H pylori et formidabelt patogen, der er ansvarligt for meget sygelighed og dødelighed i hele verden. Imidlertid forekommer H pylori-infektion i cirka halvdelen af verdens befolkning, hvor sygdom er en undtagelse snarere finish reglen. At forstå, hvordan denne organisme interagerer med sin vært, er essentiel for at formulere en clever strategi til håndtering af dens vigtigste kliniske konsekvenser. Denne gennemgang giver et indblik i H pylori-værtsbakterielle interaktioner.
Fremskridt og løfte om FDG-PET-billeddannelse til kræftpasienthåndtering og onkologisk lægemiddeludvikling.
2 – [(18) F] Fluoro-2-deoxyglucose-positronemissionstomografi (FDG-PET) vurderer en grundlæggende egenskab ved neoplasi, Warburg-effekten. Denne molekylære billeddannelsesteknik tilbyder en komplementær tilgang til anatomisk billeddannelse, der er mere følsom og specifik i visse kræftformer.
FDG-PET er blevet anvendt i vid udstrækning inden for onkologi primært som et iscenesættelses- og genoprettelsesværktøj, der kan vejlede patientpleje. Fordi den nøjagtigt detekterer tilbagevendende eller resterende sygdom, har FDG-PET også et betydeligt potentiale til vurdering af terapirespons. I denne forbindelse kan det forbedre patienthåndtering ved at identificere respondenter tidligt, inden tumorstørrelse reduceres; ikke-svar kan ophøre med meningsløs behandling.
- Endvidere korrelerer en reduktion i FDG-PET-signalet inden for dage eller uger efter påbegyndelse af terapi (for eksempel ved lymfom, ikke-lillecellet lunge og spiserørskræft) signifikant sammenhæng med langvarig overlevelse og andre kliniske slutpunkter, der nu anvendes i lægemiddelgodkendelser.
- Disse fund antyder, at FDG-PET kunne lette lægemiddeludvikling som et tidligt surrogat med klinisk fordel. Denne artikel gennemgår det videnskabelige grundlag for FDG-PET og dens udvikling og anvendelse som et værdifuldt værktøj til billedbehandling af onkologi.
- Dets potentiale til at lette lægemiddeludvikling i syv onkologiske omgivelser (lunge, lymfom, bryst, prostata, sarkom, kolorektal og æggestokk) behandles.
- Anbefalinger inkluderer preliminary validering mod godkendte behandlingsformer, retrospektive analyser til at definere størrelsen af ændringer, der indikerer respons, yderligere prospektiv validering som et surrogat med klinisk fordel, og anvendelse som et fase II / III-forsøgsendepunkt for at fremskynde evaluering og godkendelse af nye regimer og behandlingsformer.
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
| 7-04518 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
| MBS145904-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
| MBS145904-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
| MBS145904-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
| MBS145904-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
B-Cell Leukemia/Lymphoma 2 Human (Recombinant) |
|||
| 22060811-1 | Bio-WORLD | 2 µg | EUR 179.02 |
B-Cell Leukemia/Lymphoma 2 Human Recombinant |
|||
| rAP-2828 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL |
|||
| 7-04543 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL |
|||
| 7-04544 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 XL |
|||
| 7-04545 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| 7-04519 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| 7-04520 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| 7-04521 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| 7-04522 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| 7-04523 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| 7-04524 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| 7-04525 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| 7-04526 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| 7-04527 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| 7-04528 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| 7-04529 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| 7-04530 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| MBS143397-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| MBS143397-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| MBS143397-1mg | MyBiosource | 1mg | EUR 4980 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
| MBS143397-5x1mg | MyBiosource | 5x1mg | EUR 22085 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| MBS143398-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| MBS143398-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| MBS143398-1mg | MyBiosource | 1mg | EUR 4980 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
| MBS143398-5x1mg | MyBiosource | 5x1mg | EUR 22085 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| MBS143399-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| MBS143399-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| MBS143399-1mg | MyBiosource | 1mg | EUR 4980 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
| MBS143399-5x1mg | MyBiosource | 5x1mg | EUR 22085 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| MBS142966-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| MBS142966-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| MBS142966-1mg | MyBiosource | 1mg | EUR 4980 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
| MBS142966-5x1mg | MyBiosource | 5x1mg | EUR 22085 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| 7-04537 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| 7-04538 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| 7-04539 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| MBS143400-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| MBS143400-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| MBS143400-1mg | MyBiosource | 1mg | EUR 4980 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR |
|||
| MBS143400-5x1mg | MyBiosource | 5x1mg | EUR 22085 |
Human B-Cell Leukemia/Lymphoma 2 -BH4 (Recombinant) |
|||
| 22060256-1 | Bio-WORLD | 2 µg | EUR 190.94 |
B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH1) |
|||
| 22060812-1 | Bio-WORLD | 2 µg | EUR 179.02 |
B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH2) |
|||
| 22060813-1 | Bio-WORLD | 2 µg | EUR 179.02 |
B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH3) |
|||
| 22060814-1 | Bio-WORLD | 2 µg | EUR 179.02 |
B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH4) |
|||
| 22060815-1 | Bio-WORLD | 2 µg | EUR 179.02 |
B-Cell Leukemia/Lymphoma 2 Human Recombinant (-BH4) |
|||
| rAP-2834 | Angio Proteomie | Inquiry | Ask for price |
B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH1) |
|||
| rAP-2837 | Angio Proteomie | Inquiry | Ask for price |
B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH2) |
|||
| rAP-2838 | Angio Proteomie | Inquiry | Ask for price |
B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH3) |
|||
| rAP-2839 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) |
|||
| MBS143396-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) |
|||
| MBS143396-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) |
|||
| MBS143396-1mg | MyBiosource | 1mg | EUR 4980 |
Recombinant Human B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) |
|||
| MBS143396-5x1mg | MyBiosource | 5x1mg | EUR 22085 |
B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-NWGR) |
|||
| 22060816-1 | Bio-WORLD | 2 µg | EUR 179.02 |
B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿NWGR) |
|||
| rAP-2840 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 Protein |
|||
| MBS556304-0005mg | MyBiosource | 0.005mg | EUR 220 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 Protein |
|||
| MBS556304-002mg | MyBiosource | 0.02mg | EUR 320 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 Protein |
|||
| MBS556304-5x002mg | MyBiosource | 5x0.02mg | EUR 1300 |
B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) Human Recombinant |
|||
| rAP-2836 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human B-cell CLL/lymphoma 7A |
|||
| MBS146396-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-cell CLL/lymphoma 7A |
|||
| MBS146396-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-cell CLL/lymphoma 7A |
|||
| MBS146396-01mg | MyBiosource | 0.1mg | EUR 1360 |
Recombinant Human B-cell CLL/lymphoma 7A |
|||
| MBS146396-5x01mg | MyBiosource | 5x0.1mg | EUR 5800 |
Recombinant Human B-cell CLL/lymphoma 7C |
|||
| MBS145893-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human B-cell CLL/lymphoma 7C |
|||
| MBS145893-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human B-cell CLL/lymphoma 7C |
|||
| MBS145893-1mg | MyBiosource | 1mg | EUR 5345 |
Recombinant Human B-cell CLL/lymphoma 7C |
|||
| MBS145893-5x1mg | MyBiosource | 5x1mg | EUR 23725 |
Recombinant Human B-cell CLL/Lymphoma 10 |
|||
| MBS144405-0001mg | MyBiosource | 0.001mg | EUR 240 |
Recombinant Human B-cell CLL/Lymphoma 10 |
|||
| MBS144405-0005mg | MyBiosource | 0.005mg | EUR 310 |
Recombinant Human B-cell CLL/Lymphoma 10 |
|||
| MBS144405-005mg | MyBiosource | 0.05mg | EUR 1260 |
Recombinant Human B-cell CLL/Lymphoma 10 |
|||
| MBS144405-5x005mg | MyBiosource | 5x0.05mg | EUR 5345 |
B-cell CLL/Lymphoma 10 Human Recombinant |
|||
| rAP-2822 | Angio Proteomie | Inquiry | Ask for price |
B-cell CLL/lymphoma 7A Human Recombinant |
|||
| rAP-2825 | Angio Proteomie | Inquiry | Ask for price |
B-cell CLL/lymphoma 7C Human Recombinant |
|||
| rAP-2831 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag |
|||
| 7-04549 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag |
|||
| 7-04550 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag |
|||
| 7-04551 | CHI Scientific | 1mg | Ask for price |
Recombinant human B-cell lymphoma 6 protein |
|||
| P1281 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human B-cell lymphoma 6 protein |
|||
Recombinant Human B-cell lymphoma/leukemia 10 |
|||
| MBS1164977-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human B-cell lymphoma/leukemia 10 |
|||
| MBS1164977-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human B-cell lymphoma/leukemia 10 |
|||
| MBS1164977-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human B-cell lymphoma/leukemia 10 |
|||
| MBS1164977-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human B-Cell Leukemia/Lymphoma XL |
|||
| MBS143401-001mg | MyBiosource | 0.01mg | EUR 240 |
